Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Lifts Q2 Guidance Ahead Of Post-Buyout Long-Term Forecast
Teva Lifts Q2 Guidance Ahead Of Post-Buyout Long-Term Forecast
Teva Lifts Q2 Guidance Ahead Of Post-Buyout Long-Term Forecast
Submitted by
admin
on July 12, 2016 - 7:01pm
Source:
Investors.com
News Tags:
Teva Pharmaceutical
earnings
Headline:
Teva Lifts Q2 Guidance Ahead Of Post-Buyout Long-Term Forecast
Do Not Allow Advertisers to Use My Personal information
